VBI VACCINES INC CDA - COM NEW (VBIV)

CUSIP: 91822J103

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NEW
Total 13F shares
11,640,216
Share change
+507,684
Total reported value
$63,905,000
Price per share
$5.49
Number of holders
23
Value change
+$2,844,490
Number of buys
14
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 91822J103?
CUSIP 91822J103 identifies VBIV - VBI VACCINES INC CDA - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VBI VACCINES INC CDA - COM NEW (VBIV) as of Q1 2017

As of 31 Mar 2017, VBI VACCINES INC CDA - COM NEW (VBIV) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,640,216 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Clarus Ventures, LLC, Cambridge Investment Research Advisors, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, KCG HOLDINGS, INC., EAM Investors, LLC, GOLDMAN SACHS GROUP INC, and MORGAN STANLEY. This page lists 23 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.